Catherine Coste

This profile gathers the share dealings of Catherine Coste across 3 companies, led by Biolife Solutions Inc, Biomerica Inc and Minerva Surgical Inc. In total, 6 filings cover trades dated from 10 June 2022 to 6 October 2026.

Purchases make up the whole of the open-market record (1 purchase, €5,935). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants.

The latest filing, published on 8 October 2026, reports a transaction in Biolife Solutions Inc. The last purchase on record was published on 30 January 2023, which is 1,357 days ago. Typically, a trade is published a median of 3 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.